FIXX - Homology Medicines misses by $0.07 revenue in-line March, 12 2019 07:40 AM Homology Medicines Inc. Homology Medicines (NASDAQ:FIXX): Q4 GAAP EPS of -$0.51 misses by $0.07.Revenue of $0.98M (+19.5% Y/Y) in-line.Press ReleaseMore news on: Homology Medicines, Inc., Earnings news and commentary, Healthcare stocks news,